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ABSTRACT
RIZZO, M., F. GENSINI, C. FATINI, P. MANETTI, N. PUCCI, A. CAPALBO, M.C. R. VONO, AND G. GALANTI ACE I/D
Polymorphism and Cardiac Adaptations in Adolescent Athletes. Med. Sci. Sports Exerc., Vol. 35, No. 12, pp. 1986–1990, 2003.
Purpose: The aim of this cross-sectional study was to determine whether there is a correlation between left ventricular hypertrophy
(LVH) and angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism in adolescent athletes. Methods: Seventy-five
competitive soccer players (aged 15  1.2 yr) and 52 untrained control subjects (aged 15  1.6 yr) were examined with
echocardiography (echo) and bioelectrical impedance analysis. The ACE genotype of all subjects was determined by PCR and
correlated with left ventricular mass (LVM) indices. Results: Allele frequencies were comparable between athletes and controls. Body
surface area (BSA), fat-free mass (FFM), and all mean echo measurements were significantly greater in athletes than in controls. LVM
and LVM indices for both BSA and FFM were all significantly greater in athletes than in controls (LVM 195.3  32 g vs 165.3 
37.6 g; LVM/BSA 115.5  18.9 g·mq1 vs 95  18.2 g·mq1; LVM/FFM 3.5  0.5 vs 3  0.54, P  0.001 for the three variables).
Left ventricular hypertrophy was found in 17 (23%) athletes. There was no correlation between ACE I/D polymorphism and athletes
with LVH as the II and DD genotype frequencies were identical (41%). However, in athletes with LVH, the presence of the D allele
was associated with a greater LVM index than compared to homozygous II genotype (LVM  145  7.6 g·mq1 in DDID group
vs 135  2.9 g·mq1 in II group, P  0.008). Conclusions: The results of the study show that significant changes occur in cardiac
morphology and function in adolescent athletes. Interestingly, the ACE I/D polymorphism was associated with the degree of cardiac
hypertrophy but not with the occurrence of LVH itself. Key Words: ECHOCARDIOGRAPHY, LEFT VENTRICULAR MASS, LEFT
VENTRICULAR HYPERTROPHY, ACE I/D POLYMORPHISM
Long-term physical training induces morphologicaland functional cardiac adaptations that are usuallydescribed as “athlete’s heart” (21). The predominant
changes include increased left ventricular mass (LVM) and
decreased rest and submaximal heart rate. These adaptations
are beneficial and allow the heart to work as a more efficient
and powerful pump (5).
Exercise-induced cardiac morphological adaptations have
been thoroughly examined in adult athletes, whereas very
few data are available about adolescents.
A number of factors modulate LVM in athletes. These
include both intrinsic factors—gender, age, blood pressure,
body weight and composition, and hormonal influences—
and extrinsic factors, which particularly concern the type
(resistance or endurance), intensity, and length of training
(7,9,16). However, in view of the variability observed in the
LVM of similarly trained athletes, the influence of genetic
factors on cardiac mass development may be postulated.
The insertion/deletion (I/D) polymorphism of the gene
encoding for the angiotensin converting enzyme (ACE) is
known to affect changes in LVM in response to physical
training in adult athletes. In several previous studies, differ-
ent authors documented the association of the DD genotype
with physiological left ventricular hypertrophy (LVH) in
endurance athletes (4,8,12,13). This association was corre-
lated to the enhanced cardiac renin-angiotensin system
(RAS) activity in subjects who were homozygotes for the D
allele. The final effector of RAS is angiotensin II (AT II), a
powerful myocardial growth factor that results from ACE
proteolytic action. Enhanced activity of cardiac AT II in
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response to mechanical stimuli is a better explanation of the
correlation between allele D and exercise-induced left ven-
tricular hypertrophy.
At present, no data are available on the influence of the
ACE genotype on LVM changes in response to physical
training in teenage athletes.
The aim of this study was to determine whether there is
a correlation between LVH and ACE I/D polymorphism in
adolescent athletes.
MATERIALS AND METHODS
Sample selection. Over a period of 2 months, 300
male soccer players, aged 12–18 yr, underwent a prepartici-
pation screening for competitive activity at the Sports Med-
icine Reference Center. All subjects were members of the
same athletic club (A.C. Fiorentina) and had been previ-
ously divided into teams according to date of birth.
A single evaluation of all subjects was performed in the
morning, under fasting conditions, and a minimum of 36 h
from the last training session.
The first level of examination for all the athletes included
physical assessment, rest-ECG, and echocardiography. The
pubertal development stage was assessed in all the athletes
by physical examination, as defined by Marshall and Tanner
(11). According to these authors, we considered five stages
of pubertal development: T1, prepubertal stage; T2, early
puberty; T3, middle puberty; T4, late puberty; and T5,
postpubertal stage or sexual maturity. Only athletes classi-
fied as T5 were included in this study.
Athletes with valvular alteration, as assessed by echocar-
diography (bicuspid aortic valve and mitral valve prolapse)
were also included, in the presence of trivial valvular
regurgitation.
Subjects. The study population consisted of 75 male
competitive soccer players aged 14–18 (mean age  SD 
15  1.2 yr), from the A.C. Fiorentina juvenile teams, and
52 healthy volunteer age- and sex-matched controls (mean
age SD 15 1.6 yr) and comparable for pubertal stage.
At the time of the evaluation, athletes had usually been
training for over 2 yr.
The training program consisted of five sessions shared as
follows: 1) Four sessions of 2 h of endurance training
including 15 min of warm-up, 40 min of aerobic exercises,
40 min of technical exercises performed with ball (shots,
dribbling, and crossings), and 15 min of cool-down and
stretching. 2) One session of low- to moderate-intensity
resistance training including a single set of different exer-
cises (e.g., shoulder press, abdominal crunch, quadriceps
extension or leg press, leg curls, and calf rise). Each training
session lasted 30 min, and the intensity of strength training
was 60% of one-repetition maximum.
The control subjects were recruited from Florentine high
schools. Their physical activity was limited to 2 h·wk1 of
low-level training performed at school, according to the edu-
cational program applied in Italians schools. Moreover, no
control subject had been involved in any other sport activity.
The study was approved by the local Ethics Committee.
Written informed consent was obtained from all the subjects
before their participation in the study. For subjects under 18
yr of age, parental consent was also obtained.
General measurements. Height and weight were as-
sessed in all the subjects. Body surface area (BSA) was
calculated using the Dubois formula (6).
Systolic and diastolic blood pressure were measured with
a Riva-Rocci sphygmomanometer. Blood pressure was cal-
culated as the average of three measurements obtained after
5 min of supine rest at 1-min intervals.
Bioimpedance analysis. Body composition was mea-
sured with tetrapolar BIA RJL-Akern 101 (Florence, Italy)
in the supine position, according to the NIH Consensus
Statement (15). This method allowed us to evaluate fat-free
mass (FFM; Bodycomp 2.55 program with BIA analyzer),
which correlates directly to muscle mass.
Echocardiographic assessment. Studies were per-
formed with Esaote Biosound Megas (Florence, Italy) phased-
array echocardiography with transducer frequencies that were
appropriate for body size, using standard techniques. Accord-
ing to the recommendations of the American Society of Echo-
cardiography, two-dimensionally guided M-mode tracings of
left ventricular (LV) end-systolic and end-diastolic diameters
were made, and interventricular septum and posterior wall
thickness were measured (19). LV mass was calculated ac-
cording to the equation reported by Devereux (3). The early to
atrial wave ratio in left ventricular peak inflow velocities (E/A
ratio) was obtained according to Benjamin (1), wall stress was
calculated according to the equation reported by Reichek et al.
(17), and the ejection fraction was calculated with a formula
derived from Teicholz et al. (22).
DNA analysis. Genomic DNA was extracted from pe-
ripheral blood and I/D polymorphism was determined by
PCR using primers and cycling conditions as previously
described by Rigat et al. (18). DNA was amplified in the
presence of 5% dimethylsulphoxide (DMSO) in the reaction
mixture, at an annealing temperature of 60°C, in order to
reduce the mistyping of ID as DD. Fragments of 190 bp
(deletion allele, D) and 490 bp (insertion allele, I) were
separated on a 2% agarose gel, stained with ethidium bro-
mide, and viewed on a UV transilluminator. Each DD ge-
notype was moreover subjected to a second PCR amplifi-
cation without the 5% DMSO, at an annealing temperature
of 67°C, and using a primer pair that recognizes an inser-
tion-specific sequence in order to reduce underestimation of
heterozygotes.
Statistical analysis. Statistical analyses were per-
formed with the GB-STAT program. Data are presented as
mean  SD for quantitative variables. Study population
characteristics were compared using Student’s test when
Gaussian distribution was observed. Significance for all
statistical analyses was set at P  0.05.
RESULTS
Genotype distribution was in agreement with Hardy-
Weinberg equilibrium, and the allele frequencies found in
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athletes were comparable to those of controls (Table 1). The
anthropometric measurements and FFM were significantly
different between athletes and controls (Table 2).
Tables 3 and 4 show mean, SD, and 5th to 95th percentile
ranges of the echocardiographic measurements of the soccer
player cohort and those of the sedentary control group.
LV internal dimensions, septal and LV posterior wall
thicknesses, LVM and LVM corrected for both BSA and
FFM, left atrial chamber size, and right ventricular diastolic
diameter were all significantly greater in the soccer players
than in sedentary controls (LVM 195.3  32 g vs 165.3 
37.6 g; LVM/BSA 115.5  18.9 g·mq1 vs 95  18.2
g·mq1; LVM/FFM 3.5  0.5 vs 3  0.54. P  0.001 for
all the variables).
Soccer players had greater LVM, resulting from greater
chamber dimensions and wall thickness, in comparison with
untrained controls. In particular, we observed an increase in
septal thickness (41% of the athletes exceeded the 95th
percentile of the values observed in sedentary controls, see
Table 4) and in LV end-diastolic dimensions (21% of ath-
letes exceeded the 95th percentile of the values observed in
sedentary controls, see Table 4). LV systolic and diastolic
functions were not affected by increased LVM; the lower
ejection fraction observed in athletes had no clinical
relevance.
Left ventricular hypertrophy (LVH, defined as LVM/
BSA 132 g·mq1) was found in 17 athletes (23%). No
relationship between the ACE I/D polymorphism and the
development of exercise-induced cardiac hypertrophy was
found. The prevalence of the DD genotype was in fact
comparable to that of the II genotype in the hypertrophic
athletes (II  41%, ID  18%, DD  41%). In these
athletes, the level of LVH was significantly different be-
tween ACE D allele carriers and II homozygote athletes
(LVMI 145 7.6 g·mq1 in IDDD group vs 135 2.9
g·mq1 in II group, P  0.008).
DISCUSSION
Long-term physical training is associated with physiolog-
ical cardiac hypertrophy. A number of studies have inves-
tigated exercise-induced cardiac adaptations in adults,
whereas little information is available about teenagers.
In this study a group of adolescent athletes was evaluated.
The sample was homogeneous for gender, stage of sexual
maturation, lifestyle, and form of training (type, intensity,
and frequency of training sessions). Regarding the training,
soccer players undergo a prevalently isotonic type with a
small isometric component.
Athletes showed significantly higher LVM and LVM
indices than sedentary controls. It is unlikely that these
differences between the two groups were due to a previous
selection to the specific sport because soccer requires tech-
nical ability more than superior cardiovascular performance.
The greater LVM resulted from greater chamber dimen-
sions and wall thickness. Thus, from a morphological point
of view, this pattern of cardiac hypertrophy was in the
middle of the two extremes described in previous echocar-
diographic studies: eccentric hypertrophy, characterized by
increased LV internal dimensions with proportional parietal
thickening, and concentric hypertrophy, characterized by
increased wall thickness with no alterations of chamber
dimensions. The eccentric pattern has been described in
high-endurance trained athletes such as marathon runners,
cyclists, and rowers as the adaptation to the physiological
volume overload related to the isotonic exercise. On the
other hand, the concentric pattern has been described in
strength-trained athletes, such as weightlifters, as the adap-
tation to the repetitive pressure overload related to the
isometric exercise (5,7,21).
The pattern of LVH that we observed in the young soccer
players reflected the characteristics of the training program
these athletes undertook, i.e., a combined endurance and
strength training inducing a physiological repetitive volume
and pressure cardiac overload. The results of the current
study are in agreement with the findings of Somauroo et al.
(20), in spite of the fact that their subjects were more
TABLE 1. ACE Genotype distribution and allele frequency in athletes and controls.
Athletes
(N  75)
Controls
(N  52)
ACE genotype distribution
II 28% 17%
DD 29% 32%
ID 43% 51%
ACE allele frequency
I 49% 42%
D 51% 58%
TABLE 2. General data in athletes and controls.
Athletes
(N  75)
Controls
(N  52) P
Age (yr) 15  1.2 15  1.6 NS
HR (bpm) 68.3  10.4 73.7  10 0.001
Height (cm) 175.7  6.5 171.3  11.5 0.001
Weight (kg) 66.4  8.2 67  8.5 0.05
BSA (mq) 1.8  0.1 1.7  0.2 0.001
FFM (kg) 58.6  7 52  8.5 0.001
BPs (mm Hg) 117.6  8.6 118  7.4 0.05
BPd (mm Hg) 71  7.2 74.5  7.5 0.001
HR, heart rate; BSA, body surface area; FFM, fat-free mass; BPs, systolic blood
pressure; BPd, diastolic blood pressure.
TABLE 3. Echocardiographic measurements in athletes and controls.
Athletes
(N  75)
Controls
(N  52) P
AO root (mm) 29.3  2.2 28.3  2.9 0.05
LA size (mm) 34.7  3.1 32.2  3.4 0.001
RVDd (mm) 21  3.7 19.6  3 0.001
IVSd (mm) 9.5  0.1 8.5  1 0.001
LVPWd (mm) 9.5  1.1 8.3  0.9 0.001
LVIDd (mm) 51.4  4.4 49.4  3.5 0.001
LVIDs (mm) 32.1  3.6 30  3.3 0.001
LVM (g) 195.3  32 165.3  37.6 0.001
LVM/BSA (gmq1) 115.5  18.9 95  18.2 0.001
LVM/FFM (gkg1) 3.5  0.5 3  0.4 0.001
FE% 66.6  6.9 69.1  4.7 0.03
D% 38.3  5.8 38.8  3.9 NS
E/A 2  0.5 2.2  0.6 NS
AO root, aortic root; LA size, left atrium end systolic dimension; RVDd, right ventricular
end diastolic dimension; ISVd, interventricular septal end diastolic dimension; LVPWd,
left ventricular end diastolic posterior wall dimension; LVIDd, left ventricular end
diastolic internal dimension; LVIDs, left ventricular end systolic internal dimension;
LVM, left ventricular mass.
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heterogeneous with respect to age and stage of sexual
maturation.
Apart from the pattern of cardiac hypertrophy, which was
similar throughout the athletic sample, we found a wide
range of LVM and LVM indices within the same group (the
5th and the 95th percentile were LVM  146.4–247 g;
LVMI 86.7–146 g·mq1), in spite of their similar athletic
training. These findings suggest that different factors affect
LVM response to athletic training in teenagers. The athletes
of this study had been recruited from the juvenile teams of
the same athletic society, in order to minimize the differ-
ences related to the type of training and to lifestyle, both of
these being extrinsic factors that could well affect the impact
of exercise on the cardiovascular system. So, given the
relatively high degree of environmental homogeneity of the
athletic sample, we postulated that the observed variance in
LVM values among athletes was due to some underlying
genetic difference.
To our knowledge, this is the first study to examine the
relationship between ACE I/D polymorphism and LVH in
adolescent athletes. Though no relationship between LVH in
adolescent athletes and ACE I/D polymorphism was ob-
served, the D allele was associated with the degree of LVH.
Over the past few years, the I/D polymorphism of the
ACE gene has been the most investigated genetic variant for
affecting exercise-induced left ventricular hypertrophy in
adult athletes. In previous studies, different authors de-
scribed the association of the DD genotype with LVH in
athletes (4,8,12,13). Two hypotheses have been advanced to
explain this association: an increased activity of AT II, a
powerful cell growth factor, and/or increased degradation of
bradykinin, a cellular growth inhibitor, both resulting from
the enhanced myocardial ACE activity in subjects who are
homozygotes for ACE D allele (2).
Our results, regarding no influence of ACE I/D polymor-
phism on the presence of LVH, are at variance with those
found in adults by various authors. Montgomery et al. (12),
Diet et al. (4), and Nagashima et al. (13) reported a strong
association between the DD genotype and LVH in long-
term endurance-trained adult athletes. Moreover in a previ-
ous study we ourselves described the same association in a
group of adult professional soccer players (8).
The absence of a relationship between LVH and ACE
genotype in the current study highlights the fact that LVM
is influenced by a large number of environmental and bio-
logical factors, such as age, sex, race, blood pressure, ge-
netic factors, and physical training. Moreover, LVM can be
considered the result of an interaction between physiologi-
cal stimuli and transducing systems. One possible hypoth-
esis is that in adolescent athletes the influence of ACE I/D
polymorphism on the development of LVH is masked by
some other factor. In particular, insulin-like growth factor-1
(IGF-1) is an attractive candidate because: 1) IGF-1 plasma
levels have been shown to be age-dependent (10) and 2)
IGF-1 is known to be associated with cardiac hypertrophy in
trained soccer players (14). Collectively, these data provide
a possible explanation for the discrepancy between adoles-
cent and adult athletes and the impact of ACE polymor-
phism on LVH.
CONCLUSIONS
This study describes the morphological features of young
soccer players’ hearts. Soccer players have a significantly
greater left ventricular mass, resulting from the greater
chamber size and wall thickness, in comparison with that
observed in untrained controls. The pattern of this cardiac
enlargement represents an adaptation to the physiological
volume and pressure overload, which the above-mentioned
type of training involves. Thus, these findings suggest that
the main features of the athlete’s heart already described in
adults are observed in teenagers too. The ACE I/D poly-
morphism did not influence the development of LVH but
did influence the LVH levels.
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